Results 111 to 120 of about 5,593 (170)

Association Between Different Metabolic Obesity Phenotypes and Erosive Esophagitis: A Retrospective Study. [PDF]

Diabetes Metab Syndr Obes
He T, Sun XY, Tong MH, Zhang MJ, Duan ZJ.   +4 more
europepmc   +1 more source

[Use of Los Angeles Classification in Erosive Esophagitis: analysis of inter-observer and intra-observer agreement]. [PDF]

Acta Gastroenterol Latinoam
de Los Rios AA, Olmos JI, Sanguinetti JM, Wonaga A, Bortot L, González Ballerga E.   +5 more
europepmc   +1 more source

Comment on: Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study

Internal Medicine, 2018
Khazaei, S., Mansori, K., Veisani, Y.
openaire   +3 more sources

Clinical features of gastroesophageal reflux disease and erosive esophagitis: Insights from patients undergoing esophagogastroduodenoscopy in resource-limited Ethiopia. [PDF]

World J Gastroenterol
Mengistie FA, Shewaye AB, Tasamma AT, Ayalew ZS.   +3 more
europepmc   +1 more source

Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial. [PDF]

Neurogastroenterol Motil
Shin CM, Choi SC, Cho JW, Kim SY, Lee OJ, Kim DH, Cho YK, Lee JY, Lee SK, Shin JE, Kim GH, Park SY, Hong SJ, Jung HK, Lee SJ, Youn YH, Jeon SW, Sung IK, Park MI, Lee OY.   +19 more
europepmc   +1 more source

Efficacy and safety of tegoprazan (LXI-15028) vs . esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial. [PDF]

Chin Med J (Engl)
Zhu H, Xue Q, Song Y, Zhang Z, Li X, Lyu S, Zhan Q, Liu F, Lu L, Zhong L, Chen W, Shao D, Ding Y, Liu D, Yang X, Huang Z, Li Z, Du Y.   +17 more
europepmc   +1 more source

Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis. [PDF]

Ther Adv Gastroenterol
Liu Y, Gao Z, Hou X.
europepmc   +1 more source

RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262. [PDF]

J Clin Med
Jeong Y, Lee BJ, Han SH.
europepmc   +1 more source

A systematic review with meta-analysis: Efficacy and safety of potassium-competitive acid blocker compared with proton pump inhibitor in the maintenance of healed erosive esophagitis. [PDF]

JGH Open
Simadibrata DM, Lesmana E, Pratama MIA, Sugiharta AJ, Winarizal AS, Lee YY, Syam AF.   +6 more
europepmc   +1 more source

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial. [PDF]

Chin Med J (Engl)
Xiao Y, Qian J, Zhang S, Dai N, Chun HJ, Chiu C, Chong CF, Funao N, Sakurai Y, Eisner JD, Xie L, Chen M.   +11 more
europepmc   +1 more source